Caldwell Trust CO Novartis Ag Transaction History

Caldwell Trust CO

$1 Trillion
Q2 2025

A detailed history of Caldwell Trust CO transactions in Novartis Ag stock. As of the latest transaction made, Caldwell Trust CO holds 3,127 shares of NVS stock, worth $408,917. This represents 0.04% of its overall portfolio holdings.

Number of Shares

3,127

Holding current value

$408,917

% of portfolio

0.04%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Sep 22, 2025	BUY	$101.96 - $121.01 $318,828 - $378,398	3,127 New	3,127 $378 Million
Q1 2025 Sep 23, 2025	BUY	$97.14 - $115.57 $13,599 - $16,179	140 Added 4.48%	3,267 $364 Million
Q2 2024 Sep 24, 2025	SELL	$92.57 - $107.37 $9,257 - $10,737	-100 Reduced 2.92%	3,330 $355 Million
Q1 2024 Sep 24, 2025	BUY	$95.27 - $108.47 $28,866 - $32,866	303 Added 9.69%	3,430 $332 Million
Q4 2023 Oct 01, 2025	SELL	$92.27 - $101.54 $29,987 - $33,000	-325 Reduced 8.66%	3,430 $346 Million
Q1 2023 Oct 01, 2025	BUY	$80.03 - $92.81 $50,258 - $58,284	628 Added 20.08%	3,755 $345 Million
Q4 2022 Oct 01, 2025	SELL	$75.55 - $92.52 $88,015 - $107,785	-1,165 Reduced 22.53%	4,005 $363 Million
Q3 2022 Oct 01, 2025	BUY	$74.61 - $87.26 $152,428 - $178,272	2,043 Added 65.33%	5,170 $393 Million
Q2 2022 Oct 01, 2025	SELL	$80.52 - $93.75 $20,532 - $23,906	-255 Reduced 4.7%	5,171 $437 Million
Q1 2022 Oct 01, 2025	BUY	$80.11 - $90.62 $184,172 - $208,335	2,299 Added 73.52%	5,426 $476 Million
Q4 2021 Oct 02, 2025	SELL	$79.7 - $88.13 $40,487 - $44,770	-508 Reduced 8.38%	5,553 $486 Million
Q3 2021 Oct 02, 2025	SELL	$81.78 - $95.14 $10,713 - $12,463	-131 Reduced 2.12%	6,061 $496 Million
Q2 2021 Oct 02, 2025	SELL	$85.24 - $94.15 $19,605 - $21,654	-230 Reduced 3.58%	6,192 $565 Million
Q1 2021 Oct 02, 2025	BUY	$83.5 - $98.47 $275,132 - $324,458	3,295 Added 105.37%	6,422 $549 Million
Q4 2020 Oct 02, 2025	BUY	$78.07 - $94.43 $303,926 - $367,615	3,893 Added 124.5%	7,020 $663 Million
Q3 2020 Oct 02, 2025	SELL	$82.14 - $91.0 $18,070 - $20,020	-220 Reduced 2.98%	7,164 $623 Million
Q2 2020 Oct 02, 2025	SELL	$80.93 - $91.1 $18,209 - $20,497	-225 Reduced 2.96%	7,384 $645 Million
Q1 2020 Oct 02, 2025	BUY	$70.67 - $99.01 $316,742 - $443,762	4,482 Added 143.33%	7,609 $627 Million
Q4 2019 Oct 06, 2025	BUY	$84.35 - $95.37 $429,172 - $485,242	5,088 Added 162.71%	8,215 $778 Million

Others Institutions Holding NVS

# of Institutions

1,561

Shares Held

136M

Call Options Held

1.72M

Put Options Held

1.7M

Dodge & Cox San Francisco, CA

10.6M
Shares

$1.39 Billion
0.78% of portfolio
Primecap Management CO Pasadena, CA

10.4M
Shares

$1.36 Billion
1.03% of portfolio
Dimensional Fund Advisors LP Austin, TX

9.06M
Shares

$1.18 Billion
0.26% of portfolio
Morgan Stanley New York, NY

7.56M
Shares

$989 Million
0.06% of portfolio
Ken Fisher Fisher Asset Management, LLC | Camas, Wa

7.12M
Shares

$931 Million
0.35% of portfolio

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $281B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caldwell Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Caldwell Trust CO with notifications on news.

Account